Skip to content

Pinto Beans and Glycemic Control in Adults With Type 2 Diabetes

Impact of Pinto Beans as Part of a Normal Diet on Glycemic Control in Adults With Type 2 Diabetes: a Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04003194
Enrollment
13
Registered
2019-07-01
Start date
2009-03-01
Completion date
2010-12-31
Last updated
2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

pulses, legumes, Phaseolus vulgaris L., glycemic response

Brief summary

This study examines the impact of daily consumption of ½ c pinto beans, compared to a control (½ c green beans), on fasting glucose, postprandial glucose and HbA1c concentrations in adults with type 2 diabetes mellitus (T2DM).

Detailed description

This study utilized a randomized, pretest-posttest, crossover (within-group) design, that includes two treatment periods \[control period (½ c. green beans each day) and pinto beans (½ c each day)\], each 12-weeks in duration with a 4- week wash-out period to determine the impact on fasting glucose, postprandial glucose and HbA1c concentrations. After a baseline wash-in period, 16 participants are randomly assigned to 2 treatment periods \[control period and pinto beans\], each 12-weeks in duration. On 28 randomized days during the wash-in period and interventions, participants keep diet records and measure a postprandial capillary glucose concentration using a glucometer 1 hour after the meal during which the pinto beans or control are consumed. Before and after each 12-week intervention, participants provide a fasted venous blood sample for glucose and HbA1c analyses.

Interventions

The intervention was 1/2 cup of pinto beans each day.

OTHERGreen Beans - control

The control was 1/2 cup of green beans each day.

Sponsors

Iowa State University
CollaboratorOTHER
University of Colorado, Colorado Springs
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Crossover Assignment Crossover design with 2-12 week intervention and comparator phases separated by a 4-week washout.

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of T2DM by a physician; * currently attempting control of T2DM by diet or metformin; * fasting glucose ≥ 90 mg/dL (confirmed by fasting blood draw or potential participant provided lab analysis conducted within last 30 days) and/or hemoglobin A1C ≥ 6.5% (confirmed by blood draw or potential participant provided lab analysis conducted within last 30 days); * body mass index (BMI) of 22-40 kg/m2; * no unresolved health conditions and no diagnosis of gastrointestinal disease; * limited history of legume intake; * willingness to follow study protocol, scheduling, and ability to come to the testing location; * no recent weight gain or loss (\>10% over 6 months); * no use of medications and/or dietary supplements other than metformin that affected glucose; * women could not be pregnant or breastfeeding; * habitual alcohol consumption had to be less than 2 drinks per day (specifically ≤ 720 ml of beer, 240 ml of wine, or 90 ml of hard liquor).

Exclusion criteria

* Non compliance with above inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Change in Glucose12 weeks pre and postChange in fasting blood glucose levels

Secondary

MeasureTime frameDescription
Postprandial glucose1 time per week from week 1 of each intervention to week 12 of each intervention1 time per week from week 1 of each intervention to week 12 of each intervention
Change in Hemoglobin A1c12 weeks pre and postChange in Blood hemoglobin A1c

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026